Risk factors for concurrent bacteremia in adult patients with dengue.

BACKGROUND/PURPOSE Bacteremia in dengue may occur with common exposure to pathogens in association with severe organ impairment or severe dengue, which may result in death. Cohort studies identifying risk factors for concurrent bacteremia among patients with dengue are rare. METHODS We conducted a retrospective case-control study of adult patients with dengue who were admitted to the Department of Infectious Diseases at Tan Tock Seng Hospital, Singapore from 2004 to 2008. For each case of dengue with concurrent bacteremia (within the first 72 hours of admission), we selected four controls without bacteremia, who were matched on year of infection and dengue confirmation method. Conditional logistic regression was performed to identify risk factors for concurrent bacteremia. RESULTS Among 9,553 patients with dengue, 29 (0.3%) had bacteremia. Eighteen of these patients (62.1%) had concurrent bacteremia. The predominant bacteria were Staphylococcus aureus, one of which was a methicillin-resistant strain. Dengue shock syndrome occurred more frequently and hospital stay was longer among cases than among controls. Three cases did not survive, whereas none of the controls died. In multivariate analysis, being critically ill at hospital presentation was independently associated with 15 times the likelihood of a patient with dengue having concurrent bacteremia. CONCLUSION Concurrent bacteremia in adult patients with dengue is uncommon but presents atypically and results in more deaths and longer hospital stay. Given the associated mortality, collection of blood cultures and empiric antibiotic therapy may be considered in patients who are critically ill.

[1]  Saravudh Suvannadabba,et al.  Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial , 2012, The Lancet.

[2]  J. Rhee,et al.  SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS: A COMPARISON OF THE PITT BACTEREMIA SCORE AND THE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORING SYSTEMS , 2009, Shock.

[3]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[4]  A. Nisalak,et al.  Prospective Study To Determine Accuracy of Rapid Serological Assays for Diagnosis of Acute Dengue Virus Infection in Laos , 2007, Clinical and Vaccine Immunology.

[5]  A. Nisalak,et al.  Use of Recombinant Envelope Proteins for Serological Diagnosis of Dengue Virus Infection in an Immunochromatographic Assay , 2001, Clinical Diagnostic Laboratory Immunology.

[6]  Chang Yh Biostatistics 203. Survival analysis. , 2004 .

[7]  J. Low,et al.  Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study , 2011, BMC infectious diseases.

[8]  D. Fisher,et al.  Dengue mortality: reassessing the risks in transition countries. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  P. Desprès,et al.  Mechanisms of dengue virus-induced cell death. , 2003, Advances in virus research.

[10]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[11]  A. Falconar Monoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and Vaccines , 2007, Clinical and Vaccine Immunology.

[12]  Nicholas J White,et al.  Comparison of three fluid solutions for resuscitation in dengue shock syndrome. , 2005, The New England journal of medicine.

[13]  D. Christmann,et al.  Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. , 2003, Infection control and hospital epidemiology.

[14]  V. Yu,et al.  Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. , 1999, International journal of antimicrobial agents.

[15]  Kuender D Yang,et al.  Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. , 2005, The American journal of tropical medicine and hygiene.

[16]  A. Geater,et al.  Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children. , 2010, The Journal of pediatrics.

[17]  T. Lim,et al.  Identification of concurrent bacterial infection in adult patients with dengue. , 2013, The American journal of tropical medicine and hygiene.

[18]  U. Thisyakorn,et al.  Coinfections in dengue patients. , 1998, The Pediatric infectious disease journal.

[19]  A. Ong,et al.  Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[20]  Yee‐Shin Lin,et al.  Endothelial Cell Apoptosis Induced by Antibodies Against Dengue Virus Nonstructural Protein 1 Via Production of Nitric Oxide , 2002, The Journal of Immunology.

[21]  A. Leelarasamee,et al.  Etiologies of acute undifferentiated febrile illness in Thailand. , 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[22]  S. Halstead,et al.  Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. , 1991, The American journal of tropical medicine and hygiene.

[23]  Kuender D Yang,et al.  Fatal Dengue Hemorrhagic Fever in Adults: Emphasizing the Evolutionary Pre-fatal Clinical and Laboratory Manifestations , 2012, PLoS neglected tropical diseases.

[24]  T. Hien,et al.  Multicentre prospective study on dengue classification in four South‐east Asian and three Latin American countries , 2011, Tropical medicine & international health : TM & IH.

[25]  S. Halstead,et al.  Dengue vaccine development: a 75% solution? , 2012, The Lancet.

[26]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[27]  S. Halstead,et al.  Dengue , 1872, The Lancet.

[28]  E. Ooi,et al.  The performance of RT-PCR compared with a rapid serological assay for acute dengue fever in a diagnostic laboratory , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[29]  A. Osterhaus,et al.  Microbial Translocation Is Associated with Extensive Immune Activation in Dengue Virus Infected Patients with Severe Disease , 2013, PLoS neglected tropical diseases.